Predicting Response to Programmed Cell Death Protein-1 or Programmed Death-Ligand 1 Blockade in NSCLC—Is Multiplex Immunohistochemistry or Immunofluorescence the Answer?

Volume: 16, Issue: 8, Pages: 1247 - 1249
Published: Aug 1, 2021
Abstract
Although immune checkpoint inhibitors (ICIs) have provided a welcome paradigm shift in treating NSCLC with remarkable survival benefits in some patients, their success has been tempered by low response rates and difficulty in identifying accurate predictive biomarkers. Effective biomarkers to help identify responders, minimize unnecessary cost and toxicity in nonresponders, and identify when to use different combination treatments would be of...
Paper Details
Title
Predicting Response to Programmed Cell Death Protein-1 or Programmed Death-Ligand 1 Blockade in NSCLC—Is Multiplex Immunohistochemistry or Immunofluorescence the Answer?
Published Date
Aug 1, 2021
Volume
16
Issue
8
Pages
1247 - 1249
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.